The Fanconi anaemia/BRCA pathway

D'Andrea, Alan D., Grompe, Markus·2003·Nature Reviews Cancer

Cited by (823)

Items 201–300 of 823

  1. The Fanconi anemia/BRCA pathway: A coordinator of cross-link repair
    Kanchan D. Mirchandani, Alan D. D’Andrea · 2006 · Experimental Cell Research
  2. Homology-directed Fanconi anemia pathway cross-link repair is dependent on DNA replication
    Koji Nakanishi, Francesca Cavallo, Loı̈c Perrouault, Carine Giovannangeli, Mary Ellen Moynahan, Marco Barchi, Erika Brunet, Maria Jasin · 2011 · Nature Structural & Molecular Biology
  3. Oxidant Hypersensitivity of Fanconi Anemia Type C-deficient Cells Is Dependent on a Redox-regulated Apoptotic Pathway
    Mohammad Reza Saadatzadeh, Khadijeh Bijangi‐Vishehsaraei, Ping Hong, Heidi Bergmann, Laura S. Haneline · 2004 · Journal of Biological Chemistry
  4. Potential Application of Curcumin and Its Analogues in the Treatment Strategy of Patients with Primary Epithelial Ovarian Cancer
    Katarzyna Maria Terlikowska, Anna Maria Witkowska, Małgorzata Elżbieta Zujko, Bożena Dobrzycka, Slawomir Jerzy Terlikowski · 2014 · International Journal of Molecular Sciences
  5. Cdc7 kinase – A new target for drug development
    Ronan T. Swords, Devalingam Mahalingam, Michael E O'Dwyer, Corrado Santocanale, Kevin R. Kelly, Jennifer S. Carew, Francis Joseph Giles · 2009 · European Journal of Cancer
  6. Fanconi Anemia: A DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging
    Robert M. Brosh, Marina A. Bellani, Yie Liu, Michael M. Seidman · 2016 · Ageing Research Reviews
  7. The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells
    Yun‐Gui Yang, Zdenko Herceg, Koji Nakanishi, Ilja Demuth, Colette Piccoli, Jocelyne Michelon, Gabriele Hildebrand, Maria Jasin, Martin Digweed, Zhao‐Qi Wang · 2005 · Carcinogenesis
  8. DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
    Yunxiao Meng, Chi‐Wei Chen, Mingo M. H. Yung, Wei Sun, Jing Fang Sun, Zhuqing Li, Jing Li, Zongzhu Li, Wei Zhou, Stephanie S. Liu et al. · 2018 · Cancer Letters
  9. An ATR- and BRCA1-Mediated Fanconi Anemia Pathway Is Required for Activating the G2/M Checkpoint and DNA Damage Repair upon Rereplication
    Wenge Zhu, Anindya Dutta · 2006 · Molecular and Cellular Biology
  10. BRCA1 Associates with Processive RNA Polymerase II
    Susan A. Krum, Gustavo A. Miranda, Chenwei Lin, Timothy F. Lane · 2003 · Journal of Biological Chemistry
  11. Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
    Gabriela Nestal de Moraes, Laura Bella, Stefania Zona, Matthew J. Burton, Eric W.‐F. Lam · 2016 · Current Drug Targets
  12. Clinical management of BRCA1 and BRCA2 mutation carriers
    Susan M. Domchek, Barbara Weber · 2006 · Oncogene
  13. Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going
    Claudia Omarini, Giorgia Guaitoli, Stefania Pipitone, Luca I. Moscetti, Laura Cortesi, Stefano Cascinu, Federico Piacentini · 2018 · Cancer Management and Research
  14. DNA Repair Gene Polymorphisms and Risk of Pancreatic Cancer
    Donghui Li, Hideo Suzuki, Bing-Rong Liu, Jeffrey S. Morris, Jun Liu, Taro Okazaki, Yanan Li, Ping Chang, James L. Abbruzzese · 2009 · Clinical Cancer Research
  15. Multiple TPR motifs characterize the Fanconi anemia FANCG protein
    Eric Blom, Henri J. van de Vrugt, Yne de Vries, Johan P. de Winter, Fré Arwert, Hans Joenje · 2003 · DNA repair
  16. Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets
    Can-Bin Fang, Hua-Tao Wu, Manli Zhang, Jing Liu, Guo‐Jun Zhang · 2020 · Frontiers in Cell and Developmental Biology
  17. Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis
    Younghoon Kee, Jung Min Kim, Alan D. D’Andrea · 2009 · Genes & Development
  18. Fanconi anaemia proteins: Major roles in cell protection against oxidative damage
    Giovanni Pagano, Hagop Youssoufian · 2003 · BioEssays
  19. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Sheila Seal, Rita Barfoot, Hiran Jayatilake, Paula Smith, Anthony Renwick, Linda Bascombe, Lesley McGuffog, D. Gareth Evans, Diana Eccles, Douglas F. Easton et al. · 2003 · PubMed
  20. Experimental approaches to the study of primordial germ cell lineage and proliferation
    Massimo De Felici · 2004 · Human Reproduction Update
  21. Lessons learned from DNA repair defective syndromes
    Kai‐Martin Thoms, Christiane Kuschal, Steffen Emmert · 2007 · Experimental Dermatology
  22. Direct DNA Binding Activity of the Fanconi Anemia D2 Protein
    Woo-Hyun Park, Steven P. Margossian, Andrew A. Horwitz, Amanda M. Simons, Alan D. D’Andrea, Jeffrey D. Parvin · 2005 · Journal of Biological Chemistry
  23. The interplay of Fanconi anemia proteins in the DNA damage response
    XiaoZhe Wang, Alan D. D’Andrea · 2004 · DNA repair
  24. Toll-Like Receptor 9 Regulates the Lung Macrophage Phenotype and Host Immunity in Murine Pneumonia Caused byLegionella pneumophila
    Urvashi Bhan, Glenda Trujillo, Kenneth E. Lyn-Kew, Michael W. Newstead, Xianying Zeng, Cory M. Hogaboam, Arthur Μ. Krieg, Theodore J. Standiford · 2008 · Infection and Immunity
  25. Resistance of hypoxic cells to ionizing radiation is influenced by homologous recombination status
    Debbie Sprong, Hilde L. Janssen, Conchita Vens, Adrian C. Begg · 2005 · International Journal of Radiation Oncology*Biology*Physics
  26. FANCF methylation contributes to chemoselectivity in ovarian cancer
    Olufunmilayo Ibironke Olopade, Minjie Wei · 2003 · Cancer Cell
  27. Molecular analysis of sister chromatid recombination in mammalian cells
    Nadine Puget, Melodie L. Knowlton, Ralph Scully · 2004 · DNA repair
  28. Genomic instability and radiation
    John B. Little · 2003 · Journal of Radiological Protection
  29. The yeast Snm1 protein is a DNA 5′-exonuclease
    Xiaoroang Li, James Hejna, Robb E. Moses · 2004 · DNA repair
  30. The ATM/p53/p21 Pathway Influences Cell Fate Decision between Apoptosis and Senescence in Reoxygenated Hematopoietic Progenitor Cells
    Xiaoling Zhang, June Li, Daniel P. Sejas, Qishen Pang · 2005 · Journal of Biological Chemistry
  31. Oxidative Stress/Damage Induces Multimerization and Interaction of Fanconi Anemia Proteins
    Su-Jung Park, Samantha L. M. Ciccone, Brian D. Beck, Byounghoon Hwang, Brian W. Freie, D. Wade Clapp, Suk‐Hee Lee · 2004 · Journal of Biological Chemistry
  32. Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)
    Lara E. Sucheston, Hua Zhao, Song Yao, Gary Zirpoli, Song Liu, William Eric Barlow, Halle C. F. Moore, George Thomas Budd, Dawn L. Hershman, Warren Davis et al. · 2011 · Breast Cancer Research and Treatment
  33. The S phase checkpoint: When the crowd meets at the fork
    Vanesa Gottifredi, Carol L. Prives · 2005 · Seminars in Cell and Developmental Biology
  34. Downregulation of Fanconi Anemia Genes in Sporadic Head and Neck Squamous Cell Carcinoma
    Volkert B. Wreesmann, Cherry L. Estilo, David W. Eisele, Bhuvanesh Singh, Steven J. Wang · 2007 · ORL
  35. Monoubiquitylation in the Fanconi anemia DNA damage response pathway
    Arno F. Alpi, Ketan J. Patel · 2009 · DNA repair
  36. Breaking the DNA damage response to improve cervical cancer treatment
    Hylke W. Wieringa, Ate G.J. van der Zee, Elisabeth G.E. de Vries, Marcel A.T.M. van Vugt · 2015 · Cancer Treatment Reviews
  37. Bi‐allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia
    Marc D. Tischkowitz, Najim Ameziane, Quinten Waisfisz, Johan P. de Winter, Richard Harris, Toshiyasu Taniguchi, Alan D. D’Andrea, Shirley Victoria Hodgson, Christopher George Mathew, Hans Joenje · 2003 · British Journal of Haematology
  38. The role of the RB tumour suppressor pathway in oxidative stress responses in the haematopoietic system
    Kay F. Macleod · 2008 · Nature reviews. Cancer
  39. The structure of the FANCM–MHF complex reveals physical features for functional assembly
    Yuyong Tao, Changjiang Jin, Xu Li, Shali Qi, Lingluo Chu, Liwen Niu, Xuebiao Yao, Maikun Teng · 2012 · Nature Communications
  40. CDYL1 fosters double-strand break-induced transcription silencing and promotes homology-directed repair
    Enas R. Abu‐Zhayia, Samah W. Awwad, Bella M. Ben‐Oz, Hanan Khoury-Haddad, Nabieh Ayoub · 2017 · Journal of Molecular Cell Biology
  41. The DNA double-strand break response pathway: becoming more BRCAish than ever
    Nicholas S. Y. Ting, Wen‐Hwa Lee · 2004 · DNA repair
  42. Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy
    Xiaxin Li, Michelle M. Le Beau, Samantha L. M. Ciccone, Feng‐Chun Yang, Brian W. Freie, Chen Shi, Jin Yuan, Ping Hong, Attilio Orazi, Laura S. Haneline et al. · 2005 · Blood
  43. The Fanconi anemia pathway: Repairing the link between DNA damage and squamous cell carcinoma
    Lindsey E. Romick‐Rosendale, Vivian Wai Yan Lui, Jennifer Rubin Grandis, Susanne I. Wells · 2013 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  44. Current Approaches to Pancreatic Cancer Screening
    Ankit Chhoda, Lingeng Lu, Barbara M. Clerkin, Harvey A. Risch, James J. Farrell · 2018 · American Journal Of Pathology
  45. Dedicated to the core: Understanding the Fanconi anemia complex
    Allan M. Gurtan, Alan D. D’Andrea · 2006 · DNA repair
  46. DNA repair pathways and hereditary cancer susceptibility syndromes
    Malinda L Spry · 2007 · Frontiers in bioscience
  47. Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity
    Gouri Chatterjee, Judit Jiménez-Sáinz, Thomas Presti, Tiffany Tuyen Minh Nguyen, Ryan B. Jensen · 2016 · Nucleic Acids Research
  48. p97 Promotes a Conserved Mechanism of Helicase Unloading during DNA Cross-Link Repair
    George Fullbright, Halley B. Rycenga, Jordon D. Gruber, David T. Long · 2016 · Molecular and Cellular Biology
  49. Rad18-mediated Translesion Synthesis of Bulky DNA Adducts Is Coupled to Activation of the Fanconi Anemia DNA Repair Pathway
    Ihn Young Song, Komaraiah Palle, Aditi U. Gurkar, Satoshi Tateishi, Gary M. Kupfer, Cyrus Vaziri · 2010 · Journal of Biological Chemistry
  50. Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies
    Mantia-Smaldone, Edwards, Anda Vlad · 2010 · Cancer Management and Research
  51. Sub‐nuclear localization of Rad51 in response to DNA damage
    Emil Mladenov, Boyka Anachkova, Irina R. Tsaneva · 2006 · Genes to Cells
  52. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant
    Robert S. Tebbs, John M. Hinz, Nazumi Alice Yamada, James B. Wilson, Edmund P. Salazar, Cynthia B. Thomas, Irene M. Jones, Nigel J. Jones, Larry H. Thompson · 2004 · DNA repair
  53. Breast cancer prognostication and prediction in the postgenomic era
    Per Eystein Lønning, Stian Knappskog, Vidar Staalesen, Ranjan Chrisanthar, JR Lillehaug · 2007 · Annals of Oncology
  54. DNA Damage: From Chronic Inflammation to Age-Related Deterioration
    Άννα Ιωαννίδου, Evi Goulielmaki, George A. Garinis · 2016 · Frontiers in Genetics
  55. Survival of the fittest: in vivo selection and stem cell gene therapy
    Tobias Neff, Brian C. Beard, Hans‐Peter Kiem · 2005 · Blood
  56. The Fanconi anemia pathway and ubiquitin
    Céline F. Jacquemont, Toshiyasu Taniguchi · 2007 · BMC Biochemistry
  57. Epigenetic Drivers of Genetic Alterations
    Minoru Toyota, Hiromu Suzuki · 2010 · Advances in genetics
  58. Targeting abnormal DNA double strand break repair in cancer
    Feyruz Virgilia Rassool, Alan E. Tomkinson · 2010 · Cellular and Molecular Life Sciences
  59. Crosslinks and crosstalk
    Mary A. Risinger, Joanna Louise Groden · 2004 · Cancer Cell
  60. Increased Atherosclerotic Lesions in LDL Receptor Deficient Mice With Hematopoietic Nuclear Receptor Rev‐erbα Knock‐ Down
    Hongling Ma, Wenbin Zhong, Yingliang Jiang, Coralie Fontaine, Shiqian Li, Jiangnan Fu, Vesa M. Olkkonen, Bart Staels, Daoguang Yan · 2013 · Journal of the American Heart Association
  61. Heterozygosity for p53 (Trp53 +/−) Accelerates Epithelial Tumor Formation in Fanconi Anemia Complementation Group D2 (Fancd2) Knockout Mice
    Scott Robert Houghtaling, Laura A. Granville, Yassmine M. N. Akkari, Yumi Torimaru, Susan B. Olson, Milton J. Finegold, Markus Grompe · 2005 · Cancer Research
  62. Triamcinolone acetonide activates an anti-inflammatory and folate receptor–positive macrophage that prevents osteophytosis in vivo
    M. Siebelt, Nicoline M. Korthagen, Wu Wei, Harald C. Groen, Yvonne M. Bastiaansen-Jenniskens, C. Müller, Jan Hendrik Waarsing, Marion de Jong, Harrie Weinans · 2015 · Arthritis Research & Therapy
  63. FANCD2 and DNA Damage
    Manoj K. Nepal, Raymond Che, Chi Ma, Jun Zhang, Peiwen Fei · 2017 · International Journal of Molecular Sciences
  64. Fanconi anemia in Ashkenazi Jews
    David Ivan Kutler, Arleen D. Auerbach · 2004 · Familial Cancer
  65. Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells
    Xiaoling Zhang, June Li, Daniel P. Sejas, Qishen Pang · 2005 · Blood
  66. Efficient Deletion of Normal Brca2-Deficient Intestinal Epithelium by Poly(ADP-Ribose) Polymerase Inhibition Models Potential Prophylactic Therapy
    Trevor Hay, Helen Jenkins, Owen James Sansom, Niall M.B. Martin, Graeme C.M. Smith, Alan Richard Clarke · 2005 · Cancer Research
  67. Fanconi Anemia Complementation Group FANCD2 Protein Serine 331 Phosphorylation Is Important for Fanconi Anemia Pathway Function and BRCA2 Interaction
    Gang Zhi, James B. Wilson, Xiaoyong Chen, Diane S. Krause, Yuxuan Xiao, Nigel J. Jones, Gary M. Kupfer · 2009 · Cancer Research
  68. Epigenetic Deregulation of DNA Repair and Its Potential for Therapy
    Monika E. Hegi, Davide Sciuscio, Anastasia Murat, Marc Levivier, Roger Stupp · 2009 · Clinical Cancer Research
  69. XRCC2 and XRCC3 Regulate the Balance between Short- and Long-Tract Gene Conversions between Sister Chromatids
    Ganesh Nagaraju, Andrea J. Hartlerode, Amy Kwok, Gurushankar Chandramouly, Ralph Scully · 2009 · Molecular and Cellular Biology
  70. Homozygous disruption of PDZD7 by reciprocal translocation in a consanguineous family: a new member of the Usher syndrome protein interactome causing congenital hearing impairment
    Eberhard Schneider, Tina Märker, Angelika Daser, Gabriele Frey-Mahn, Vera Beyer, Ruxandra Farcas, Brigitte Schneider-Rätzke, Nicolai Kohlschmidt, Bärbel Grossmann, Katharina Bauß et al. · 2008 · Human Molecular Genetics
  71. Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining
    Scott Robert Houghtaling, Amy Hanlon Newell, Yassmine M. N. Akkari, Toshiyasu Taniguchi, Susan B. Olson, Markus Grompe · 2005 · Human Molecular Genetics
  72. Targeted Disruption of FANCC and FANCG in Human Cancer Provides a Preclinical Model for Specific Therapeutic Options
    Eike Gallmeier, Eric S. Calhoun, Carlo Rago, Jonathan Robert Brody, Steven Clark Cunningham, Tomáš Hucl, Myriam Gorospe, Manu Kohli, Christoph Lengauer C, Scott E. Kern · 2006 · Gastroenterology
  73. CtBP1 Is Expressed in Melanoma and Represses the Transcription of p16INK4a and Brca1
    Hui Deng, Jing Liu, Yu Deng, Gangwen Han, Yiqun G. Shellman, Steven E. Robinson, John J. Tentler, William Allen Robinson, David Albert Norris, Xiao‐Jing Wang et al. · 2013 · Journal of Investigative Dermatology
  74. Replication Stress, Defective S-phase Checkpoint and Increased Death in Plk2-Deficient Human Cancer Cells
    Elizabeth M. Matthew, Tim J. Yen, David T. Dicker, Jay F. Dorsey, Wensheng Yang, Arunasalam Navaraj, Wafik S. El‐Deiry · 2007 · Cell Cycle
  75. Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer
    Alex Lyakhovich, Jordi Surrallés · 2005 · Cancer Letters
  76. Death by Abl: A Matter of Location
    Jiangyu Zhu, Jean Y. J. Wang · 2004 · Current topics in developmental biology/Current Topics in Developmental Biology
  77. Improvement of spinal non-viral IL-10gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain
    Ellen C. Dengler, Lauren A Alberti, Brandi N. Bowman, Audra A. Kerwin, Jenny L. Wilkerson, Daniel R Moezzi, Eugene Limanovich, James Alfred Wallace, Erin D. Milligan · 2014 · Journal of Neuroinflammation
  78. Expression Signature Defined by FOXM1–CCNB1 Activation Predicts Disease Recurrence in Non–Muscle-Invasive Bladder Cancer
    Seon‐Kyu Kim, Yun-Gil Roh, Kiejung Park, Tae‐Hong Kang, Wun‐Jae Kim, Ju‐Seog Lee, Sun-Hee Leem, In‐Sun Chu · 2014 · Clinical Cancer Research
  79. Nucleophosmin Regulates Cell Cycle Progression and Stress Response in Hematopoietic Stem/Progenitor Cells
    June Li, Daniel P. Sejas, Reena Rani, Tara Koretsky, Grover C. Bagby, Qishen Pang · 2006 · Journal of Biological Chemistry
  80. Regulation of hematopoietic stem cell fate by the ubiquitin proteasome system
    Kelly Moran-Crusio, Linsey B. Reavie, Iannis Aifantis · 2012 · Trends in Immunology
  81. Regulation of stem cell function by protein ubiquitylation
    Alexandros Strikoudis, María Guillamot, Iannis Aifantis · 2014 · EMBO Reports
  82. Fanconi DNA repair pathway is required for survival and long‐term maintenance of neural progenitors
    Karine Sii-Felice, Olivier Etienne, Françoise Hoffschir, Céline Mathieu, Lydia Riou, Vilma Barroca, Céline Haton, Fré Arwert, Pierre Fouchet, François Dominique Boussin et al. · 2008 · The EMBO Journal
  83. Crosstalk between BRCA‐Fanconi anemia and mismatch repair pathways prevents MSH2‐dependent aberrant DNA damage responses
    Min Peng, Jenny Xie, Anna J. Ucher, Janet Stavnezer, Sharon B. Cantor · 2014 · The EMBO Journal
  84. Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance
    Per Eystein Lønning · 2004 · Trends in Molecular Medicine
  85. The FANC pathway and mitosis: A replication legacy
    Valeria Naim, Filippo Rosselli · 2009 · Cell Cycle
  86. Activation of DNA damage signaling
    Mats E. Ljungman · 2005 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  87. The Fanconi Anemia Proteins Functionally Interact with the Protein Kinase Regulated by RNA (PKR)
    Xiaoling Zhang, June Li, Daniel P. Sejas, Keaney R. Rathbun, Grover C. Bagby, Qishen Pang · 2004 · Journal of Biological Chemistry
  88. Targeting DNA repair in breast cancer: A clinical and translational update
    Eitan Amir, Boštjan Šeruga, Rosario Serrano, Alberto Ocaña · 2010 · Cancer Treatment Reviews
  89. Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
    Kyunghee Burkitt, Mats E. Ljungman · 2008 · Molecular Cancer
  90. Protective immunity to liver-stage malaria
    Lauren E. Holz, Daniel Fernandez-Ruiz, W. Heath · 2016 · Clinical & Translational Immunology
  91. FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
    Yu Sun, Zhuo Wang, Na Lei, Dan Feng Dong, Wei Wang, Chenghai Zhao · 2020 · Cell Death and Disease
  92. DNA double-strand break repair and development
    E R Phillips, Peter J. McKinnon · 2007 · Oncogene
  93. Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest
    Jeanho Yun, Qing Zhong, Jong‐Young Kwak, Wen‐Hwa Lee · 2005 · Oncogene
  94. The WD40 Repeats of FANCL Are Required for Fanconi Anemia Core Complex Assembly
    Allan M. Gurtan, Patricia Stuckert, Alan D. D’Andrea · 2006 · Journal of Biological Chemistry
  95. αII-Spectrin interacts with five groups of functionally important proteins in the nucleus
    Deepa Sridharan, Laura McMahon, M LAMBERT · 2006 · Cell Biology International
  96. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer
    Aaron Lewis, James M. Flanagan, Anna J. Marsh, Gulietta M. Pupo, Graham J. Mann, Amanda B. Spurdle, Geoffrey John Lindeman, Jane E. Visvader, Melissa A. Brown, Georgia Chenevix‐Trench · 2005 · Breast Cancer Research
  97. Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer
    Petra van der Groep, Michael Hoelzel, Horst Buerger, Hans Joenje, Johan P. de Winter, P. J. van Diest · 2007 · Breast Cancer Research and Treatment
  98. No formation of DNA double-strand breaks and no activation of recombination repair with UVA
    Rizzo, Jennifer L., Dunn, Jessica, Rees, Adam, Rünger, Thomas M. · 2011 · Journal of Investigative Dermatology
  99. Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer
    S.L. Lim, P Smith, Nelofer Syed, Corneel Coens, Helen H. Wong, Maria van der Burg, Piotr W. Szlosarek, Tim Crook, J A Green · 2008 · British Journal of Cancer
  100. Mouse models of DNA double-strand break repair and neurological disease
    Pierre‐Olivier Frappart, Peter J. McKinnon · 2008 · DNA repair